INTRODUCTION
Screening of cells and human tissues for DNA damage is commonly conducted in order to correlate the action of clastogenic agents with human disease (1) (2) (3) (4) (5) (6) . Two aspects of DNA damage that have received considerable attention in recent years are the generation and measurement of apurinic/apyrimidinic (AP) sites and of mismatched DNA bases (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Both lesions are considered promutagenic (7, 17) . AP sites occur spontaneously, as a result of DNA damage, or as an intermediate in the action of excision repair enzymes (18) (19) (20) (21) . When unrepaired, AP sites may direct polymerases to preferentially insert adenine in the opposite strand, thus promoting base substitution mutations (22) . Base mismatches, on the other hand, occur as a result of errors in DNA replication by polymerases or by spontaneous chemical changes (e.g. deamination of methylcytosine to thymine; 17) or as a result of unrepaired oxidative DNA damage (23) . The excision repair of mismatches by glycosylases generates AP sites as intermediates (7, 8, 17) . Recent findings suggest a definite correlation between defects in the mismatch repair mechanism and cancer (24) (25) (26) . The ability to sensitively and efficiently screen cells and tissues for AP sites and mismatches would be of major interest, as detection of these forms of DNA damage could have a direct correlation with clinical endpoints. In addition, most assays that can quantitate mismatches have also been eventually utilized for detection of point mutations (27) (28) (29) (30) (31) (32) (33) (34) (35) , thereby allowing screening for another endpoint of major clinical significance.
Several methods for measuring AP sites have been reported, which generally allow the measurement of AP sites at the femtomole (10 -15 mol; 10-13) or sub-femtomole (14) levels. Several of these methods require radioactivity (9, 10, 12) . On the other hand, measurement of mismatches is a more difficult task, and assays used to detect DNA mismatches have had varying degrees of success (27) (28) (29) (30) (31) (32) (33) (34) (35) . Assays that utilize mismatch cleavage (27, 31) or mismatch repair (32, 33) The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors increasingly used due to the associated convenience and specificity (34) . A drawback of most enzymatic methods, however, is that normal DNA containing no mismatches is also recognized by the enzymes to some extent, thus posing limits to the technology (34) . A mismatch repair enzyme that lacks any activity on normal DNA is MutY (35) (36) (37) . Gel electrophoresis-based methods that utilize Escherichia coli MutY to detect mismatches and mutations reported highly selective activity towards mismatched adenine by this enzyme (38) . However, the use of gel electrophoresis poses restrictions as to the size and composition of DNA sequences that can be examined at a time, and cannot be used for genome-wide scanning of mismatches or for examining numerous samples at once. In addition, it can be laborious and it requires radioactivity.
The present work reports on a novel, non-isotopic methodology to detect AP sites or MutY-recognized mismatches in genomic DNA, based on the trapping of associated aldehydes by a new fluorescent aldehyde-reactive probe (FARP) (Fig. 1) . FARP is a fluoresceine-conjugated derivative of hydroxylamine that forms stable oxime bonds with aldehydes and is unreactive towards normal DNA structures and 3′ OH ends (39) . Both DNA depurination or excision repair of adenine in DNA by MutY result in open chain aldehydes (17) . We describe the development of a new chemiluminescence methodology (diagrammatically shown in Fig. 1 ) to detect FARP-trapped aldehyde-containing AP sites on DNA. Subsequently, we demonstrate that MutY-recognized mismatches in DNA may also be detected with high sensitivity and specificity following FARP labeling and chemiluminescence measurement. The new methodology for detection of AP sites and MutY-recognized mismatches is performed on a microplate format, and small (∼50 bp) as well as large (>1000 bp) DNA segments can be conveniently and rapidly examined, either for AP sites or for MutY-recognized mismatches, depending on the desired endpoint.
MATERIALS AND METHODS

DNA, oligomers and chemicals
FARP [5-(((2-(carbohydrazino)-methyl) thio) acetyl)-aminofluorescein, aminooxyacetyl hydrazide] was synthesized as described (39) . High purity genomic calf thymus DNA and double-stranded ladder (pUC18 MspI digest, 26-501 bp) was purchased from Sigma Chemical and used without further purification. Single-stranded (+strand) M13 DNA was purchased from Pharmacia Biotech and pGXIs14 plasmid DNA, a gift from Professor MacLeod (MD Anderson Cancer Center) was isolated from the host bacteria as described earlier (39) . Both agarose gel electrophoresis and the absorbance ratio at 260-280 nm were performed to determine the purity of the plasmid. Gel-purified 49mer oligonucleotides representing the TFIIIA transcription factor-binding sequence of the Xenopus rRNA gene (enumerated in Table 1 ) were supplied by Oligos Etc Inc. Enzyme MutY (E.coli) was purchased from Trevigen Inc. and stored as recommended by the manufacturers. Hydroxylamine purchased from Sigma Chemical was always freshly made prior to the experiments. GTG agarose was obtained from FMC Bioproducts, polyacrylamide gel electrophoresis reagents were from National Diagnostics while SYBR GOLD nucleic acid gel stain and Picogreen™ DNA quantitation dye was supplied by Molecular Probes. For chemiluminescence studies, Reacti-Bind NeutrAvidin coated polystyrene plates (pre-blocked with bovine serum albumin) were supplied by Pierce. Anti-fluorescein-Fab fragments (Sheep)-alkaline phosphatase conjugate (antiF-Fab-AP) was purchased from Boehringer Mannheim. CDP-Star, a 1,2-dioxetane chemiluminescent enzyme substrate and Emerald-II™ enhancer used with CDP-Star was purchased from TROPIX Inc. Micro Bio-Spin G25 chromatography columns were obtained from Bio-Rad laboratories. Label IT™ Nucleic Acid biotinylation kit was purchased from PanVera Inc. All reagents and buffers were of analytical grade and made with ultrapure water (1800 Mohm m -1 resistivity) delivered by an Alpha-Q system (Millipore).
Acidic or physiological depurination of calf thymus DNA: treatment with hydroxylamine
Aldehyde-containing AP sites were chemically induced in calf thymus or plasmid DNA by a short exposure (0-60 s) to acidic conditions (pH 3.5) over a set time period at a temperature of 38_C, as described earlier (39) . The reaction was halted by placing the sample quickly on ice and adding a neutralization solution (10% of 3 M sodium acetate and 1 M potassium phosphate buffer at pH 7 and 7.5, respectively), to a final volume of 50 µl. AP sites were also slowly generated in calf thymus DNA via spontaneous depurination at 37_C, pH 7.0, over a period of days, and these were monitored with the present assay. Prior to incubation at 37_C, the DNA was treated with 5 mM hydroxylamine for 1 h at room temperature to remove traces of existing aldehydes from the pool of potential FARP-binding sites. The hydroxylamine was then removed via G25 ultracentrifugation and the sample was resuspended in sodium phosphate buffer, pH 7.
FARP trapping of aldehydes and subsequent DNA biotinylation
To covalently trap open-chain aldehydes generated in DNA at the position of AP sites, 500 µM FARP was reacted with ∼100 ng DNA in 40 mM sodium citrate pH 7.0 at 15-22_C for 30 min. In some experiments, FARP labeling of DNA was performed simultaneously with the depurination reaction. Non-covalently bound FARP was removed by G25 ultracentrifugation. FARP-labeled DNA was either used on the same day or stored at 4 or -20_C for a few days prior to further experiments. To immobilize FARPlabeled DNA onto neutravidin microplates, the DNA was exposed for 1 h to a commercially available biotinylation reagent (Biotin Label IT™ reagent, 1 µl reagent/µg DNA, in MOPS buffer, pH 7.5, at 37_C). Excess reagent was then removed by G25 ultracentrifugation. The samples were either used immediately or stored at 4_C for a few days, prior to chemiluminescent studies.
Chemiluminescence measurement of FARP-trapped aldehydes in calf thymus or plasmid DNA
Double-stranded DNA, doubly-labeled with FARP and biotin, was immobilized onto neutravidin-coated microplate strips, in the presence of 5 nM antiF-Fab-AP. In a typical experiment, 50-100 ng of doubly-labeled DNA plus 5 nM antiF-Fab-AP in a total volume of 50 µl were incubated at room temperature for 1 h in TE buffer, pH 7.5. Unbound sample and antiF-Fab-AP were removed by pipetting and washing with TE at least four times. The microplate strips were then transfered into 50 ml polypropylene tubes and washed four times in 30-50 ml of TE buffer with constant agitation for 10 min. The chemiluminescent substrates (CDP-Star plus Emerald II enhancer) were then added in 0.1 M diethanolamine, pH 8.5, and the antiF-Fab-AP-catalyzed dephosphorylation of CDP-Star reaction was carried out at room temperature for 1 h, after which maximum light generation was achieved. In separate experiments to quantitate the fraction of biotinylated DNA captured on microplates, Picogreen™ dye was used to measure double-stranded DNA just prior and after its removal from neutravidin-coated plates.
Chemiluminescence instrumentation
The low light from the chemiluminescence reaction was detected using an intensified charged coupled device (ICCD) system (Princeton Instruments). This ICCD camera utilizes a proximity focused microchannel plate (MCP) image intensifier, fiber-optically coupled to the CCD array. The entire area of the ICCD is capable of light detection, giving a total of 576 × 384 pixels on a Pentium ® PC computer screen. Both the intensifier and CCD are cooled to -35_C thermoelectrically and the dark current is <50 c.p.m. The ICCD was used to detect total light generation from each cell of the microplate strip. Cells were individually placed in a reproducible geometry at short distance from the ICCD and the total light output per second measured. The background chemiluminescence (signal measured when FARP was omitted from the procedure) was routinely subtracted from all samples. All measurements were repeated at least three times.
Formation of homoduplex and heteroduplex oligonucleotides
49mer oligonucleotides and their complementary strands with or without a centrally located T-to-G base substitution were synthesized. In another synthesis of the same oligomers, 5′ biotinylated 49mers and their complementary unbiotinylated strands were synthesized (Table 1 ). For hybridization, equimolar amounts (∼0.5 µg) of each oligonucleotide were annealed in 40 mM Tris-HCl (pH 7.5), 20 mM MgCl 2 and 50 mM NaCl to form duplex oligonucleotides. The mixture was first heated to 95_C for 2 min, then allowed to hybridize at 65_C for 3 h and cooled slowly to room temperature. Following hybridization, the double-stranded 49mers were treated with hydroxylamine (5 mM in citrate pH 7.0, for 30 min, 25_C) to remove traces of spontaneously or heat-generated aldehydes from the pool of FARP-reactive sites.
Treatment of M13 DNA, ladder DNA and duplex oligonucleotides with MutY and gel electrophoresis
Test DNA (single-stranded M13, ladder DNA or duplex oligonucleotide) (50 ng) was incubated for 1 h at 37_C with 0-1.0 U MutY in 40 mM Na-citrate buffer (pH 7.0) and then alkali-treated to convert positions of missing adenines to strand breaks. Analysis of cleavage products for single-stranded M13 DNA was done by agarose gel electrophoresis (0.9% agarose, run overnight at 20 V in 1× TBE buffer and stained with 1 µg/ml ethidium bromide). Fragment analysis for ladder DNA and oligonucleotides was done by 16% denaturing polyacrylamide gel electrophoresis in the presence of 7.5 M urea at 20 V/cm. The DNA fragments were detected by SYBR Gold dye or by ethidium staining and photographs taken using an Eagle Eye™ Still Video (Stratagene).
Chemiluminescence measurement of FARP-trapped mismatches in oligonucleotides, ladder and M13 DNA M13 DNA, ladder DNA or 5′-biotinylated oligonucleotide duplexes, hydroxylamine treated, were exposed to MutY, FARP labeled, and biotinylated with the protocols described above. The biotinylation step was omitted for the oligonucleotides since these were pre-biotinylated. Typically, 50 ng from the doubly (biotin plus FARP)-labeled nucleic acids were applied on neutravidincoated microplates and their chemiluminescence measured. Figure 2A shows chemiluminescence obtained with the present setup when serial dilutions of free alkaline phosphatase were added to CDP-STAR R substrate and Emerald II enhancer and measured using the cooled ICCD. The chemiluminescence detection limit of this setup is <0.01 amol alkaline phosphatase. Examination of the buildup of alkaline phosphatase chemiluminescent signal in solution following addition of substrate plus enhancer at room temperature demonstrates that after 60 min a relatively constant value is achieved ( Fig. 2A, inset) . Therefore, all measurements reported were conducted 60-80 min following addition of the substrate. To estimate the fraction of biotinylated DNA captured on the neutravidin-coated microplates, biotinylated nucleic acid was quantitated using the fluorescence of Picogreen™ dye prior to its application and immediately following complete removal of unbound DNA from microplates. Oligonucleotides and calf thymus DNA yielded (8 ± 2)% and (11 ± 3)% DNA binding on the plates, respectively (Fig. 2B ). An average of ∼10% DNA binding on the plates was therefore assumed for all subsequent calculations.
RESULTS
Dual labeling of DNA and chemiluminescence detection using the present protocol
Ultrasensitive detection of aldehydes in DNA
Chemiluminescence detection of aldehyde-containing AP sites generated in 100 ng plasmid DNA following depurination in sodium citrate, pH 3.5, at 38_C for up to 60 s and trapping of AP sites by FARP is depicted in Figure 3 . The induction of luminescence is linear with respect to depurination exposure. The curve has been forced through zero by subtracting from all points the luminescence at zero depurination. The inset, from an earlier work (39) , demonstrates detection of fluorescence following FARPlabeling of this same plasmid exposed under identical conditions to higher depurination times (0-60 min). The fluorescence-based approach is less sensitive than the present method; however, it allows direct quantitation of the number of FARP molecules per DNA base pair, as well as the absolute number of AP sites measured (39) . Five minutes depurination of 1 µg DNA resulted in fluorescence originating from 88.2 fmol AP sites, or 1 AP site/34 000 bases (39) . Assuming a linear decrease of AP sites for lower depurination exposures, the 15 s exposure in Figure 3 corresponds to ∼1 AP site/7 × 10 5 bases. Considering also the data of Figure 2B , the amount of microplate-captured DNA generating the chemiluminescence signal for 15 s depurination is ∼10 ng. Therefore, the absolute number of AP sites recorded following 15 s depurination is ∼43 amol (see right axis in Fig. 3) .
To estimate the lowest number AP sites detectable, hydroxylamine treatment of genomic calf thymus DNA was first employed to remove traces of pre-existing AP sites [e.g. AP sites expected to be present (14, 19) in genomic DNA from mammalian cells prior to DNA extraction, plus AP sites generated-or removed-during handling]. Hydroxylamine is a small molecule and is expected to react rapidly with aldehydes, as previously demonstrated for methoxyamine (10) , thereby prohibiting subsequently added FARP to react at the same positions. Figure 4A depicts the decrease in the chemiluminescence signal obtained following hydroxylamine treatment of genomic calf thymus DNA undepurinated, or depurinated for 15 s. Following hydroxylamine removal and reaction with FARP, the chemiluminescence was reduced to almost background levels (∼500 U luminescence), which defines the current limit of this method. According to Figure 3 , 500 U luminescence correspond to ∼2 amol AP sites, or 1 AP site/2 × 10 7 bases, using a starting DNA material of 100 ng of which ∼10 ng are captured on the microplate. When hydroxylamine-treated calf thymus DNA was kept at 37_C, phosphate buffer pH 7, and assayed for AP sites via FARP as a function of time, a linear increase in spontaneously-generated aldehydic AP sites (3-425 amol) was detected (Fig. 4B) . DNA kept at 4_C under similar conditions did not display any increase in luminescence signal (Fig. 4B) . 
Gel electrophoresis of MutY-treated oligonucleotides and single-stranded M13 DNA
49mer oligomers engineered to form a double-stranded structure, with or without a centrally located A/G mismatch upon hybridization, were exposed to MutY, alkali treated and examined upon denaturing gel electrophoresis. Generation of the two expected fragments was observed for the heteroduplex oligomers, while no cutting was present in the homoduplexes (Fig. 5A) . Under the conditions applied, the fragmented DNA was ∼30% of the total DNA per lane, as quantified by a microdensitometer. This is significantly <50% of the total DNA per lane, which would result if all A/G mismatches were acted upon by MutY. The homoduplexcontaining double-stranded DNA ladder (26-501 bp fragments) did not demonstrate additional fragmentation following enzymatic treatment (Fig. 5B) . In contrast, MutY treatment of the 7249 base-long M13 single-stranded DNA resulted, presumably via generation of mismatches by self-complementation, to the generation of approximately six fragments, the smallest of which is ∼1000 bases long, as demonstrated in Figure 5C . Figure 5C also demonstrates that MutY has no activity on double-stranded plasmid, neither in the presence nor absence of single-stranded M13 (lanes 3-5) . If it is assumed that each enzymatically recognized site is cut with <100% efficiency by MutY, then three DNA fragments occur per cut site: the two DNA fragments plus the original one. Therefore, from Figure 5C , lane 2, it can be inferred that, to generate six discrete fragments, an average of about three MutY-recognized cutting sites are generated per each 7249 base-long M13 molecule.
FARP-based chemiluminescence detection of mismatches in high and low molecular weight DNA
Starting with 100 ng of biotinylated 49mer homoduplexes or heteroduplexes, the nucleic acid was treated successively with hydroxylamine, MutY, then FARP, and applied on neutravidin microplates for chemiluminescence detection of mismatches. A strong signal was obtained for A/G mismatch-containing oligonucleotides (Fig. 6 ), corresponding to 49mers simultaneously bound by the immobilized neutravidin and by the antiF-Fab-AP. No signal was obtained when MutY was omitted, or when oligonucleotides without mismatch were MutY treated. A mixture of double-stranded homoduplexes (DNA ladder, presumed to contain no mismatches) treated in the same way also demonstrated absence of chemiluminescence signals (Fig. 7) . In contrast, single-stranded M13 demonstrated a chemiluminescence signal of about 100 times the signal obtained without MutY, indicating the generation of FARPreactive sites following MutY treatment (Fig. 7) . The chemiluminescence results agree with the fragmentation results obtained by gel electrophoresis (Fig. 5) . Since MutY possesses an associated lyase activity (23, 26 ; Trevigen Inc., personal communication), it is possible that labeling of MutY-digested M13 DNA with FARP occurs at positions of the generated 3′ aldehydes, as well as AP-aldehydes. 
DISCUSSION
Both AP sites and base mismatches in DNA can lead to mutagenesis (7, 17) . In an attempt to develop methods sensitive enough to perform AP site detection and mismatch scanning in cells and tissues, we utilized a recently developed FARP (39) to quantitate AP sites via chemiluminescence. Unlike hydrazine (-NH-NH 2 )-based probes, hydroxylamine (-O-NH 2 )-based compounds such as FARP react very specifically with aldehydes and show no detectable cross-reactivity with other DNA components (10, 13, 39) . Previous quantitations of AP sites have demonstrated femtomole (10 -15 mol) level sensitivity (9) (10) (11) (12) (13) . In the most sensitive AP site detection method reported, Nakamura et al. (14) , using a biotin probe, detected ∼1 AP site/4 × 10 6 bases in a slot-blot based protocol requiring a starting DNA material of 15 µg. In the current approach, starting from 100 ng DNA, attomole (10 -18 mol) level detection of AP sites is obtained, and ∼1 AP site/ 2 × 10 7 bases is detected. Since the overall sensitivity of any method is directly related to the total DNA that can be introduced into a particular assay system (40) , the ability to perform the assay with nanogram-amount DNA is very significant. Therefore, depending on the chosen criterion, the current microplate-based method extends the limits of AP detection by 1-2 orders of magnitude. By using FARP to quantitate spontaneously generated AP sites in double-stranded genomic calf thymus DNA at physiological conditions, it was derived that ∼1.7 AP sites/10 6 nucleotides/day are generated (Fig. 4B) . This translates to 10 200 AP sites generated/day/mammalian genome (∼6 × 10 9 bases) and is in agreement with calculated (10 000 AP sites/cell/day; 7) and measured (9000 AP sites/cell/day; 14) values.
During excision repair of dA:dG, dA:oxodG and to a lesser extent dA:dC mismatches, the E.coli MutY glycosylase removes the adenine via complex chemistry (23, (35) (36) (37) which generates an aldehyde on the sugar (17) . We took advantage of this fact to covalently trap positions of mismatched adenine with FARP, and subsequently detect it with a sensitive chemiluminescence procedure. Unlike other mismatch-recognizing enzymes (27, 31, 33) , MutY has no reported glycosylase activity on normal DNA (23, (35) (36) (37) (38) , thereby allowing highly specific recognition of mismatches. In agreement to these expectations, the data in Figures 5-7 demonstrate that the action of MutY on DNA is a necessary and sufficient condition for generation of chemiluminescence signals. Using the present method it is possible to screen diverse and large DNA fragments for MutY-recognized mismatches in a single experiment, something practically unachievable by gel electrophoresis or current mismatch detection methods. In addition, base substitution mutations can be measured by technologies detecting mismatches (27) (28) (29) (30) (31) (32) (33) (34) (35) . Thereby the possibility opens up for high-throughput screening of another endpoint of major clinical significance using the present approach.
In conclusion, a highly sensitive method to detect aldehydecontaining AP sites in DNA was developed, on the basis of which a technique to perform mismatch scanning in long and diverse DNA fragments was devised. The amount of starting nucleic acid required for the assay is small (∼100 ng), and the application is simple and can be automated to analyze several samples simultaneously on microplates. It is anticipated that this technology may be used to sensitively scan diverse genes in cells and tissues for AP sites, mismatches and potentially base substitution mutations.
